These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 6301792
21. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects. Laubie M, Schiavi P, Vincent M, Schmitt H. J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763 [Abstract] [Full Text] [Related]
22. The effect of renal function on enalapril kinetics. Lowenthal DT, Irvin JD, Merrill D, Saris S, Ulm E, Goldstein S, Hichens M, Klein L, Till A, Harris K. Clin Pharmacol Ther; 1985 Dec; 38(6):661-6. PubMed ID: 2998676 [Abstract] [Full Text] [Related]
23. Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition. Johnston CI, Jackson B, McGrath B, Matthews G, Arnolda L. J Hypertens Suppl; 1983 Oct; 1(1):71-5. PubMed ID: 6100611 [Abstract] [Full Text] [Related]
24. Effects of the new angiotensin-converting enzyme inhibitor imidapril on renal hemodynamics and function in anesthetized dogs. Nishiyama S, Kanno K, Yoneda H, Yano K, Yamaguchi I. Arzneimittelforschung; 1992 Apr; 42(4):451-6. PubMed ID: 1322673 [Abstract] [Full Text] [Related]
26. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure. Sweet CS, Ludden CT, Frederick CM, Bush LR, Ribeiro LG. J Cardiovasc Pharmacol; 1984 Dec; 6(6):1067-75. PubMed ID: 6084762 [Abstract] [Full Text] [Related]
27. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system. Biollaz J, Schelling JL, Jacot Des Combes B, Brunner DB, Desponds G, Brunner HR, Ulm EH, Hichens M, Gomez HJ. Br J Clin Pharmacol; 1982 Sep; 14(3):363-8. PubMed ID: 6289859 [Abstract] [Full Text] [Related]
28. Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907. Ryan MJ, Boucher DM, Cohen DM, Olszewski BJ, Singer RM, Smith RD, Kaplan HR. Fed Proc; 1984 Apr; 43(5):1330-2. PubMed ID: 6323224 [Abstract] [Full Text] [Related]
29. Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat. Berecek KH, Nagahama S, Oparil S. J Hypertens Suppl; 1984 Dec; 2(3):S63-6. PubMed ID: 6100756 [Abstract] [Full Text] [Related]
30. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure. Sweet CS, Gaul SL, Reitz PM, Blaine EH, Ribeiro LT. J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609 [Abstract] [Full Text] [Related]
34. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system]. Jover B, Dupont M, Casellas D, Mimran A. Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235 [Abstract] [Full Text] [Related]
35. Enalapril, a new nonsulfhydryl angiotensin converting enzyme inhibitor, does not potentiate morphine analgesia. Mojaverian P, Swanson BN, Ferguson RK. Eur J Pharmacol; 1984 Feb 17; 98(2):303-6. PubMed ID: 6325220 [Abstract] [Full Text] [Related]
36. Influence of food on the bioavailability of enalapril. Swanson BN, Vlasses PH, Ferguson RK, Bergquist PA, Till AE, Irvin JD, Harris K. J Pharm Sci; 1984 Nov 17; 73(11):1655-7. PubMed ID: 6097665 [Abstract] [Full Text] [Related]
37. The chemistry of enalapril. Patchett AA. Br J Clin Pharmacol; 1984 Nov 17; 18 Suppl 2(Suppl 2):201S-207S. PubMed ID: 6085275 [Abstract] [Full Text] [Related]
38. Effects of repeated doses of enalapril on renal function in man. McNabb WR, Noormohamed FH, Brooks BA, Till AE, Lant AF. Br J Clin Pharmacol; 1985 Mar 17; 19(3):353-61. PubMed ID: 2985103 [Abstract] [Full Text] [Related]